Journal article
Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice
International journal of molecular sciences, Vol.23(7579), p.7579
07/01/2022
DOI: 10.3390/ijms23147579
PMCID: PMC9316262
PMID: 35886926
Abstract
Duchenne muscular dystrophy (DMD) is a congenital myopathy caused by mutations in the dystrophin gene. DMD pathology is marked by myositis, muscle fiber degeneration, and eventual muscle replacement by fibrosis and adipose tissue. Satellite cells (SC) are muscle stem cells critical for muscle regeneration. Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that promotes SC proliferation, regulates lymphocyte trafficking, and is irreversibly degraded by sphingosine phosphate lyase (SPL). Here, we show that SPL is virtually absent in normal human and murine skeletal muscle but highly expressed in inflammatory infiltrates and degenerating fibers of dystrophic DMD muscle. In mdx mice that model DMD, high SPL expression is correlated with dysregulated S1P metabolism. Perinatal delivery of the SPL inhibitor LX2931 to mdx mice augmented muscle S1P and SC numbers, reduced leukocytes in peripheral blood and skeletal muscle, and attenuated muscle inflammation and degeneration. The effect on SC was also observed in SCID/mdx mice that lack mature T and B lymphocytes. Transcriptional profiling in the skeletal muscles of LX2931-treated vs. control mdx mice demonstrated changes in innate and adaptive immune functions, plasma membrane interactions with the extracellular matrix (ECM), and axon guidance, a known function of SC. Our cumulative findings suggest that by raising muscle S1P and simultaneously disrupting the chemotactic gradient required for lymphocyte egress, SPL inhibition exerts a combination of muscle-intrinsic and systemic effects that are beneficial in the context of muscular dystrophy.
Details
- Title: Subtitle
- Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice
- Creators
- Anabel S. De la Garza-Rodea - University of California, San FranciscoSteven A. Moore - University of IowaJesus Zamora-Pineda - University of California, San FranciscoEric P. Hoffman - Binghamton UniversityKarishma Mistry - University of California, San FranciscoAshok Kumar - University of California, San FranciscoJonathan B. Strober - UCSF Benioff Children's HospitalPiming Zhao - University of California, San FranciscoJung H. Suh - University of California, San FranciscoJulie D. Saba - University of California, San Francisco
- Resource Type
- Journal article
- Publication Details
- International journal of molecular sciences, Vol.23(7579), p.7579
- DOI
- 10.3390/ijms23147579
- PMID
- 35886926
- PMCID
- PMC9316262
- NLM abbreviation
- Int J Mol Sci
- ISSN
- 1661-6596
- eISSN
- 1422-0067
- Publisher
- MDPI AG
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: GM66954, P50NS053672; DOI: 10.13039/100005202, name: Muscular Dystrophy Association, award: MDA217712; DOI: 10.13039/100007557, name: California Institute of Regenerative Medicine, award: TG2-01164
- Language
- English
- Date published
- 07/01/2022
- Academic Unit
- Pathology
- Record Identifier
- 9984276446202771
Metrics
9 Record Views